phytic acid has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janus, SC; Ondrey, FG; Weurtz, B | 1 |
| Cheng, L; Du, J; Gu, Z; Hong, Y; Li, C; Li, Z; Zhang, Y; Zhao, B | 1 |
2 other study(ies) available for phytic acid and paclitaxel
| Article | Year |
|---|---|
Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Drug Synergism; Genes, Reporter; Humans; Mouth Neoplasms; NF-kappa B; Paclitaxel; Phytic Acid | 2007 |
Polysaccharide-coated porous starch-based oral carrier for paclitaxel: Adsorption and sustained release in colon.
Topics: Adsorption; Chitosan; Colon; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Excipients; Microspheres; Paclitaxel; Phytic Acid; Porosity; Starch | 2022 |